Novel antihyperglycemic terpenoid-quinones from Pycnanthus angolensis

Journal of Organic Chemistry

Volumn 65, Issue 20, 2000, Pages 6534-6539

  Fort, Diana M ^a,b   Ubillas, Rosa P ^a,c   Mendez, Christopher D ^a,d   Jolad, Shivanand D ^a   Inman, Wayne D ^a,e   Carney, John R ^a,f   Chen, Jian Lu ^a   Ianiro, Teodoro T ^a,g   Hasbun, Carlos ^a   Bruening, Reimar C ^a,h   Luo, Jian ^a,i   Reed, Michael J ^a,d   Iwu, Maurice ^a,j   Carlson, Thomas J ^a   King, Steven R ^a   Bierer, Donald E ^a,k   Cooper, Raymond ^a,g  

^a Shaman Pharmaceuticals Inc   (United States)

^b Pharmanex Inc   (United States)

^c Phytera Inc   (United States)

^d AMGEN INC   (United States)

^e Promega Biosciences Inc   (United States)

^f KOSAN BIOSCIENCES INC   (United States)

^g Pharmanex Inc   (United States)

^h Ingenium Pharmaceuticals AG   (Germany)

ⁱ Metabolex Inc   (United States)

^j Biorsrc Devmt and Conserv Program   (Nigeria)

^k BAYER CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ORAL ANTIDIABETIC AGENT; PLANT EXTRACT; PYCNANTHUQUINONE A; PYCNANTHUQUINONE B; QUINONE DERIVATIVE; TERPENOID; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ISOLATION; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYTOCHEMISTRY; TREATMENT OUTCOME;

AFRICA; ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS; EATING; FATTY ACIDS, UNSATURATED; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NAPHTHOQUINONES; PLANT EXTRACTS; PLANT LEAVES; PLANT STEMS; PLANTS, MEDICINAL;

EID: 18744423786     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo000568q     Document Type: Article

References (33)

1. (a) Tempesta, M. S.; King, S. R. In Annual Reports in Medicinal Chemistry; Bristol, J. A, Sr. Ed.; Venuti, M. C., Ed.; Academic Press: San Diego, 1994; Vol. 29, pp 325-330.
2. (b) Carlson, T. J.; Cooper, R.; King, S. R.; Rozhon, E. J. In Photochemical Diversity; Wrigley, S., Hayes, M., Thomas, R., Crystal, E., Eds.; Royal Society Chemistry: London, 1997; pp 84-95.
3. (c) King, S. R.; Tempesta, M. S. In Ethnobotany and the Search for New Drugs. Ciba Foundation Symposium 185; Chadwick, D. J., Marsh, J., Eds.; John Wiley and Sons: Chichester/New York, 1994; pp 197-213.
4. (d) Cox, P. A. In Ethnobotany and the Search for New Drugs. Ciba Foundation Symposium 185; Chadwick, D. J., Marsh, J., Eds.; John Wiley and Sons: Chichester/New York, 1994; pp 25-36.
5. (e) Cox, P. A.; Balick, M. J. Sci. Am. 1994, June, 82-87.
6. Oubré, A. Y.; Carlson, T. J.; King, S. R.; Reaven, G. M. Diabetologia 1997, 40, 614-617.
7. Chronic fungal infections are a clinical problem commonly seen in patients with uncontrolled hyperglycemia. See: Gill, G. V. In Textbook of Diabetes; Pickup, J., William, G., Eds.; Blackwell Scientific Publications: London, 1991; pp 24-29.
8. Our dereplication process involved literature searches on plants of interest using NAPRALERT, a natural products database maintained at the Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL 60612.
9. (a) Bierer, D. E.; Fort, D. M.; Mendez, C. D.; Luo, J.; Imbach, P. A.; Dubenko, L. G.; Jolad, S. D.; Gerber, R. E.; Litvak, J.; Lu, Q.; Zhang, P.; Reed, M. J.; Waldeck, N.; Bruening, R. C.; Noamesi, B. K.; Hector, R. F.; Carlson, T. J.; King, S. R. J. Med. Chem. 1998, 41, 894-901.
10. (b) Luo, J.; Fort, D. M.; Carlson, T. J.; Noamesi, B. K.; nii-Amon-Kotei, D.; King, S. R.;Tsai, J.; Quan, J.; Hobensack, C.; Lapresca, P.; Waldeck, N.; Mendez, C. D.; Jolad, S. D.; Bierer, D. E.; Reaven, G. M. Diabetes Med. 1998, 15, 367-374.
11. (c) Fort, D. M.; Litvak, J.; Chen, J. L.; Lu, Q.; Phuan, P. W.; Cooper, R.; Bierer, D. E. J. Nat Prod. 1998, 61, 1528-1530.
12. (d) Inman, W. D.; Luo, J.; Jolad, S. D.; King, S. R.; Cooper, R. J. Nat Prod. 1999, 62, 1088-1092.
13. (e) Ubillas, R. P.; Mendez, C. D.; Jolad, S. D.; Luo, J.; King, S. R.; Carlson, T. J.; Fort, D. M. Planta Med. 1999, 65, 778-779.
14. Based on Shaman Pharmaceuticals field research in collaboration with the Ewe culture in Ghana.
15. Based on Shaman Pharmaceuticals field research in collaboration with the Igbo, Ibo, Doko, Eko, and Efik cultures in Southeastern Nigeria.
16. Vasileva, B. Plantes Medicinales de Guinee; Conakry, Moscow University: Moscow, 1969.
17. Viera, A. Subsidio para o Estudo da Flora Medicinal da Guinea Portuaguesa; Agencia General do Ultramar: Lisboa, Portugal, 1959.
18. Keay, R. W.; Onochie, C. F. A.; Stanfield, D. P. Nigerian Trees; Federal Department of Forest Research Publication: Ibadan, Nigeria, 1964.
19. Ayensu, E. S. Medicinal Plants of West Africa; Reference Publications: Algonac, Michigan, 1978.
20. Akendengué, B.; Louis, A. M. J. Ethnopharmacol. 1994, 41, 193-200.
21. Akendengué, B. J. Ethnopharmacol. 1992, 37, 165-173.
22. Noguiera, P. L.; Correia Alves, A.; Fátima C. De Araújo, M. Garcia Orta 1960, 8, 327-331.
23. Omobuwajo, O. R.; Adesanya, S. A.; Babalola, G. O. Phytochemistry 1992, 31, 1013-1014.
24. Lok, C. M.; Groenewegen, A.; Stroink, J. B. A.; Ward, J. P. Phytochemistry 1983, 22, 1973-1976.
25. Njoku, C. J.; Hopp, D. C.; Alali, F.; Asuzu, I. U.; McLaughlin, J. L. Planta Med. 1997, 63, 580-581.
26. Previously reported as SP-18904 and SP-18905, respectively. See: Luo, J.; Cheung, J.; Yevich, E. M.; Clark, J. P.; Tsai, J.; Lapresca, P.; Ubillas, R. P.; Fort, D. M.; Carlson, T. J.; Hector, R. F.; King, S. R.; Mendez, C. D.; Jolad, S. D.; Reaven, G. M. J. Pharmacol. Exp. Ther. 1999, 288, 529-534.
27. The leaves and stems of P. angolensis were separately analyzed for their content of 1 and 2. The leaves were found to contain a consistently higher yield of compounds 1 and 2.
28. Fu, X.; Hossain, M. B.; van der Helm, D.; Schmitz, F. J. J. Am. Chem. Soc. 1994, 116, 12125-12126.
29. Thomson, R. H., Naturally Occurring Quinones, Academic Press: London; 1971, 2nd ed., pp 44-49.
30. Cooper, R.; Unger, S. J. Antibiot. 1985, 38, 24-29.
31. Compounds 1 and 2 are amorphous solids. We attempted to crystallize 1 and 2 in many solvents but were unsuccessful. We also prepared various derivatives of 1 and 2 (for example, p-bromobenzoates) for NMR and X-ray crystallography studies but were unsuccessful in ascertaining the relative stereochemistry at C-8 using derivatives by NMR and were unsuccessful in obtaining crystals suitable for X-ray studies.
32. Kusumi, T.; Shibata, Y.; Ishitsuka, M.; Kinoshita, T.; Kakisawa, H. Chem. Lett. 1979, 277-278.
33. Metformin is commonly prescribed to treat Type II diabetic patients and is known as Glucophage.